Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in vascular dementia
NCT00165737Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2003
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of donepezil in vascular dementia (3 arms), sponsored by Eisai Co., Ltd. Primary endpoints: Vascular-Alzheimer's Disease Assessment Scale-Cognitive subscale at 24 weeks, Clinician's Interview-Based Impression of Change-Plus Version at 24 weeks and 1 more. Started Mar 2003; status: completed.
02
Drugs
donepezil
03
Conditions
vascular dementia
Beyond the preview
Go deeper on NCT00165737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165737.